verified_user
Standardful
Homechevron_rightStandardschevron_rightGMP (cGMP)
ActiveInternational Standardupdate Last Updated: Ongoing

GMP (cGMP)

Good Manufacturing Practice — WHO Guidelines & FDA 21 CFR 210/211

apartmentPublishing Organization:World Health Organization (WHO) / U.S. Food and Drug Administration (FDA)

Standard Introduction

Good Manufacturing Practice (GMP, or cGMP for “current” GMP) is a system of guidelines ensuring that pharmaceutical products, food, biologicals, and medical devices are consistently produced and controlled according to quality standards. The World Health Organization first published GMP guidelines in 1969, and over 100 countries have incorporated WHO GMP provisions into their national laws. In the United States, the FDA enforces cGMP regulations under 21 CFR Parts 210 and 211.

GMP covers all aspects of production — from personnel qualification and facility design to raw material controls, process validation, quality control testing, and distribution. The principles require that manufacturers document and validate every step of production, maintain clean and controlled facilities, use qualified equipment, and keep thorough records. Regulatory agencies worldwide conduct inspections to verify compliance, and violations can result in warning letters, product recalls, facility shutdowns, and criminal prosecution.

science

Quality Assurance Framework

Ensures pharmaceutical and food products are consistently produced and controlled according to quality standards appropriate to their intended use.

public

Global Regulatory Foundation

Over 100 countries have incorporated WHO GMP provisions into their national medicines laws. The FDA enforces cGMP through 21 CFR Parts 210 and 211.

verified

Production & Control Standards

Covers personnel qualification, facility design, equipment validation, raw material controls, production processes, quality control testing, and documentation.

list_alt Core GMP Principles

  • Personnel qualification, training, and hygiene
  • Premises and equipment design and maintenance
  • Documentation and record keeping
  • Production process validation and control
  • Quality control and laboratory testing
  • Complaint handling and product recalls
  • Self-inspection and quality audits
  • Sanitation and contamination prevention

Who Needs to Comply?

groups

Manufacturers of pharmaceutical products, active pharmaceutical ingredients (APIs), biologicals, vaccines, medical devices, food products, and cosmetics. Required by virtually every national regulatory authority worldwide.

Key Requirements

1

Quality Management System

Establish a comprehensive quality management system covering production and quality control, with a designated quality unit independent of production responsible for release of finished products.

2

Process Validation

Validate manufacturing processes to demonstrate they consistently produce product meeting predetermined specifications and quality attributes. Maintain ongoing process verification.

3

Documentation & Records

Maintain complete batch production records, equipment logs, laboratory records, and standard operating procedures. All records must be contemporaneous, attributable, and indelible.

4

Facility & Equipment Controls

Design and maintain facilities and equipment to prevent contamination, mix-ups, and errors. Implement qualification protocols (IQ/OQ/PQ) for critical equipment.

5

Quality Control Testing

Operate adequately equipped laboratories with trained personnel to test raw materials, intermediates, and finished products against established specifications before release.

Penalties & Enforcement

warning

FDA penalties include warning letters, product seizures, injunctions, facility shutdowns, consent decrees, and criminal prosecution. Adulterated drugs under 21 USC 331 can result in fines up to $500,000 and imprisonment up to 3 years. WHO prequalification loss bars products from UN procurement.

Official Documentation

View All

Implementation Timeline

gavel
1962
US Congress mandates FDA to require GMP for drugs (Kefauver-Harris Amendment)
public
1969
WHO publishes first GMP guidelines as part of Certification Scheme
description
1978
FDA finalizes 21 CFR Parts 210 and 211 (cGMP for finished pharmaceuticals)
science
2000
ICH Q7 GMP guide for Active Pharmaceutical Ingredients published
update
2014
WHO TRS 986 Annex 2 updated GMP guidelines published
new_releases
2025
FDA issues updated guidance on pharmaceutical CGMP practices

Related Categories